查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402599

溶瘤病毒治療市場：依產品類型、應用、開發階段、分銷管道、地區

Oncolytic Virus Therapy Market, By Product Type, By Application, By Development Stage, By Distribution Channel, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球溶瘤病毒療法市場顯著成長，預計到 2030 年將達到 4,610 萬美元。這比 2023 年的 940 萬美元顯著增加，反映出 2023 年至 2030 年期間 25.5% 的顯著年複合成長率（CAGR）。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 940萬美元
實際資料 2018-2021 預測期 2023-2030
預測期複合年成長率 25.50% 2030年市場規模預測 4610 萬美元
圖 1. 2023 年溶瘤病毒治療的全球市場佔有率(%)（依地區）
溶瘤病毒治療市場-IMG1

溶瘤病毒療法是一種很有前景的癌症治療方法，它利用工程病毒選擇性地靶向和破壞癌細胞，同時保護健康細胞。病毒性癌症治療的概念可以追溯到20世紀初。隨著基因工程的進步，該領域在 20 世紀 90 年代獲得了發展勢頭，使科學家能夠修改病毒以提高腫瘤特異性和治療效果。溶瘤病毒可以感染癌細胞並在其中複製，誘導細胞裂解或刺激針對腫瘤的免疫反應。正在進行的研究重點是最佳化病毒平台、開發聯合治療以及擴大溶瘤病毒療法在各種癌症類型中的應用。學術界、製藥公司和研究機構之間的合作研究有可能推動新型癌症溶細胞病毒療法的開發，並推動癌症治療方法。

市場動態：

在病毒工程的進步、對癌症生物學的更好理解、成功的臨床試驗以及對創新癌症治療的需求的推動下，全球溶瘤病毒治療市場正在經歷強勁成長。此外，探索新的癌症適應症、改善治療效果的聯合治療、個人化醫療方法以及開發具有增強特性的下一代病毒預計將在不久的將來提供光明的市場機會。市場趨勢包括病毒治療平台、標靶輸送系統和免疫調節策略的進步，以及解決該領域的製造和商業化課題。此外，市場相關人員正專注於透過合作研究開發新藥，預計將推動全球 Oncolyte 病毒治療市場的成長。例如，2023年6月29日，後期生物製藥公司Genelux Corporation和TVAX Biomedical, Inc.宣布，美國專利商標局將主張一種將疫苗增強的過繼性T細胞療法與溶瘤病毒療法相結合的方法.宣布已獲得一項專利該專利獨家授權給 V2ACT Therapeutics, LLC，這是 Licensing 和 TVAX 之間的合資企業，旨在開發和測試 V2ACT 免疫療法。專利到期，之後將進行專利延期，這將為V2ACT免疫療法增加實質的智慧財產權保護。

然而，有限的臨床證據、交付和分銷的課題、與治療相關的高成本以及治療的副作用預計將阻礙市場成長。克服這些課題對於最大限度地提高溶瘤病毒療法的效率和更廣泛地普及至關重要。

本研究的主要特點

  • 本報告對全球溶瘤病毒治療市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030年）的市場規模和復合年成長率。
  • 本報告還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 該報告根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球溶瘤病毒治療市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球溶瘤病毒治療市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
  • 病毒工程的進展
  • 加深對癌症生物學的理解
  • 成功的臨床試驗結果
  • 創新癌症治療的需要
  • 治療費用高昂
  • 治療的副作用
  • 尋找新的癌症適應症
  • 合併治療以改善治療效果
  • 個人化醫療方法
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章溶瘤病毒治療市場－冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章溶瘤病毒治療市場，依產品類型，2018-2030

  • 單純皰疹病毒
  • 腺病毒
  • 痘苗病毒
  • 呼腸孤病毒
  • 麻疹病毒
  • 其他（新城疫病毒、水痘口炎病毒）

第6章溶瘤病毒治療市場，依應用分類，2018-2030

  • 黑色素瘤
  • 乳癌
  • 頭頸癌
  • 膀胱癌
  • 攝護腺癌
  • 肺癌
  • 其他（如大腸直腸癌）

第7章 溶瘤病毒治療市場，依發展階段分類，2018-2030

  • 商業的
  • 管道階段
  • 臨床前
  • 第一階段
  • 第二階段
  • 第三階段

第8章溶瘤病毒治療市場，依通路，2018-2030

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章溶瘤病毒治療市場，依地區，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章競爭形勢

  • Amgen Inc.
  • Merck & Co., Inc.
  • Oncolytics Biotech Inc.
  • Circio Holding ASA
  • Akamis Bio
  • Vyriad, Inc.
  • SillaJen Biotherapeutics
  • Cold Genesys Inc.
  • Sorrento Therapeutics, Inc.
  • Takara Bio Inc.
  • Replimune Group Inc.
  • Genelux Corporation
  • Synthetic Biologics, Inc
  • Lokon Pharma AB
  • Elicera Therapeutics

第11章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5916

The global market for oncolytic virus therapy is projected to experience substantial growth, with an estimated value of US$ 46.1 Mn by 2030. This represents a significant increase from US$ 9.4 Mn in 2023, reflecting a remarkable compound annual growth rate (CAGR) of 25.5% during the period of 2023-2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 9.4 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 25.50% 2030 Value Projection: US$ 46.1 Mn
Figure 1. Global Oncolytic Virus Therapy Market Share (%), by Region, 2023
Oncolytic Virus Therapy Market - IMG1

Oncolytic virus therapy is a promising approach to cancer treatment that utilizes modified viruses to selectively target and destroy cancer cells while sparing healthy cells. The concept for viruses for cancer treatment dates back to the early 20th century, when researchers observed tumor regression in patients with viral infections. The field gained momentum in the 1990s with advancements in genetic engineering, enabling scientists to modify viruses to enhance the tumor-specificity and therapeutic efficacy. Oncolytic viruses can infect cancer cells, replicate within them, and induce cell lysis or stimulate immune responses against the tumor. Ongoing research focuses on optimizing viral platforms, developing combination therapies, and expanding the application of oncolytic virus therapy to various cancer types. Collaborations between academia, pharmaceutical companies, and research institutions drive the development of novel oncolytic virus therapies and hold promise for advancing cancer treatment approaches.

Market Dynamics:

The global oncolytic virus therapy market is witnessing strong growth on account of growing advancements in viral engineering, increasing understanding of cancer biology, successful clinical trial results, and the need for innovative cancer treatments. Moreover, exploring new cancer indications, combining therapies for improved outcomes, personalized medicine approaches, and the development of next-generation viruses with enhanced characteristics are expected to bring bright market opportunities in the near future. The market trends include advancements in virotherapy platforms, targeted delivery systems, immune modulation strategies, and addressing manufacturing and commercialization challenges in the field. Moreover, market players are focused on developing novel drugs by collaborating, which is expected to drive the growth of global oncolytic virus therapy market. For instance, on June 29, 2023, Genelux Corporation, a late clinical-stage biopharmaceutical company, and TVAX Biomedical, Inc., a late clinical-stage biopharmaceutical company, announced that the U.S. Patent and Trademark Office granted a patent claiming methods of combining vaccine-enhanced adoptive T cell therapy with oncolytic virus adjunct therapy. The patent has been exclusively licensed to V2ACT Therapeutics, LLC, a joint venture between Genelux and TVAX that was established for the purpose of developing and testing V2ACT immunotherapy. The patent expiry, prior to any patent term extension, will be in 2036 and will add substantial intellectual property protection for V2ACT immunotherapy.

However, limited clinical evidence, delivery and distribution challenges, high costs associated with treatment, and side effects of treatment are expected to hamper market growth. Overcoming these challenges is essential to maximizing the efficiency and broader adoption of oncolytic virus therapies.

Key features of the study:

  • This report provides in-depth analysis of the global oncolytic virus therapy market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global oncolytic virus therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study Amgen Inc., Merck & Co., Inc., Oncolytics Biotech Inc., Circio Holding ASA, Akamis Bio, Vyriad, Inc., SillaJen Biotherapeutics, Cold Genesys Inc., Sorrento Therapeutics, Inc., Takara Bio Inc., Replimune Group Inc., Genelux Corporation, Synthetic Biologics, Inc., Lokon Pharma AB, and Elicera Therapeutics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global oncolytic virus therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oncolytic virus therapy market

Detailed Segmentation:

  • Global Oncolytic Virus Therapy Market, By Product Type:
    • Herpes simplex virus
    • Adenovirus
    • Vaccinia virus
    • Reovirus
    • Measles virus
    • Others (Newcastle disease virus, Vesicular stomatitis virus)
  • Global Oncolytic Virus Therapy Market, By Application:
    • Melanoma
    • Breast cancer
    • Head and neck cancer
    • Bladder Cancer
    • Prostate Cancer
    • Lung Cancer
    • Others (Colorectal Cancer, and among Others)
  • Global Oncolytic Virus Therapy Market, By Development Stage:
    • Commercial
    • Pipeline Phase
    • Pre-clinical
    • Phase I
    • Phase II
    • Phase III
  • Global Oncolytic Virus Therapy Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Oncolytic Virus Therapy Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • Amgen Inc.
    • Merck & Co., Inc.
    • Oncolytics Biotech Inc.
    • Circio Holding ASA
    • Akamis Bio
    • Vyriad, Inc.
    • SillaJen Biotherapeutics
    • Cold Genesys Inc.
    • Sorrento Therapeutics, Inc.
    • Takara Bio Inc.
    • Replimune Group Inc.
    • Genelux Corporation
    • Synthetic Biologics, Inc.
    • Lokon Pharma AB
    • Elicera Therapeutics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Oncolytic Virus Therapy Market, By Product Type
    • Global Oncolytic Virus Therapy Market, By Application
    • Global Oncolytic Virus Therapy Market, By Development Stage
    • Global Oncolytic Virus Therapy Market, By Distribution Channel
    • Global Oncolytic Virus Therapy Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Advancements in Viral Engineering
  • Increasing Understanding of Cancer Biology
  • Successful Clinical Trial Results
  • Need for Innovative Cancer Treatments
    • Restraints
  • High cost associated with treatment
  • Side effects of treatment
    • Opportunities
  • Exploring new cancer indications
  • Combining therapies for improved outcomes
  • Personalized medicine approaches
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Oncolytic Virus Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Oncolytic Virus Therapy Market , By Product Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Herpes Simplex Virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Adenovirus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Vaccinia virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Reovirus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Measles virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others (Newcastle disease virus, Vesicular stomatitis virus)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Oncolytic Virus Therapy Market , By Application, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Melanoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Breast cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
  • Head and neck cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
  • Bladder Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others (Colorectal Cancer, and among Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Oncolytic Virus Therapy Market, By Development Stage, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Commercial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Pipeline Phase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III

8. Oncolytic Virus Therapy Market , By Distribution Channel, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Oncolytic Virus Therapy Market , By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.K
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
  • Oncolytics Biotech Inc.
  • Circio Holding ASA
  • Akamis Bio
  • Vyriad, Inc.
  • SillaJen Biotherapeutics
  • Cold Genesys Inc.
  • Sorrento Therapeutics, Inc.
  • Takara Bio Inc.
  • Replimune Group Inc.
  • Genelux Corporation
  • Synthetic Biologics, Inc
  • Lokon Pharma AB
  • Elicera Therapeutics
  • Analyst Views

11. Section

  • Research Methodology
  • About us